Back
Veracyte Stock Predictions
Sponsored
VCYT
Sponsored
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
68
VCYT
Veracyte
Last Price:
35.91
Seasonality Move:
7.09%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Veracyte Stock Forecast
- Over the next 52 weeks, Veracyte has on average historically risen by 23.1% based on the past 10 years of stock performance.
- Veracyte has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
-
Is Veracyte Stock Undervalued?
The current Veracyte [VCYT] share price is $35.93. The Score for VCYT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal. - VCYT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Veracyte Stock Go Up Next Year?
- Over the next 52 weeks, Veracyte has on average historically risen by 23.1% based on the past 10 years of stock performance.
Veracyte Stock Rating
Buy
68
Veracyte (VCYT)
is a Buy
Is Veracyte overpriced?
- Veracyte has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Veracyte Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
veracyte.com
52-Week Data
52-Week High:
36.26
52-Week Low:
18.61
Prediction Charts
Market Cap:
2.76B
Price in USD:
35.93
Volume:
886.52K
Beta:
1.47
Technical Analysis
SMA50:
32.93
SMA100:
28.84
SMA200:
25.54
52-Wk Change:
46.89%
Stock Predictions
-
Is Veracyte stock public?
Yes, Veracyte is a publicly traded company. -
What is the Veracyte stock quote today?
The Veracyte stock price is 35.93 USD today. -
How to buy Veracyte stock online?
You can buy Veracyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 34.42 | 34.72 | 35.15 | 34.23 |
Oct-18 | 34.31 | 34.44 | 34.48 | 33.81 |
Oct-21 | 34.38 | 33.12 | 34.44 | 33.06 |
Oct-22 | 32.87 | 32.60 | 32.87 | 32.21 |
Oct-23 | 32.42 | 32.45 | 32.47 | 31.93 |
Oct-24 | 32.82 | 32.78 | 33.22 | 32.29 |
Oct-25 | 32.95 | 33.03 | 33.62 | 32.84 |
Oct-28 | 33.27 | 34.12 | 34.36 | 33.13 |
Oct-29 | 33.77 | 34.38 | 34.46 | 33.62 |
Oct-30 | 33.93 | 35.00 | 35.29 | 33.76 |
Oct-31 | 34.75 | 33.74 | 34.75 | 33.62 |
Nov-1 | 33.96 | 34.31 | 34.36 | 33.61 |
Nov-4 | 34.22 | 35.02 | 35.03 | 33.56 |
Nov-5 | 34.77 | 35.93 | 36.26 | 34.41 |
Veracyte Earnings
Veracyte Earnings Report: Per Share Veracyte Earnings Q1 Q2 Q3 and Q4 last year and next year.
Veracyte Forecast Revenue Growth
Veracyte Stock Analysis: Historical quarterly revenues per share for Veracyte and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.10 per share.
* Veracyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.